NEWS ROOM

See the latest news from our company below or use the search feature. For more information, contact our head office or the Marketing Communications Manager directly at marcom@arazygroup.com.


 

MEET MDSAP TRANSITION DEADLINE TO CONTINUE TRADING ON CANADIAN MARKET

by Arazy Group | Mar 21, 2017
In vitro diagnostic (IVD) and medical device manufacturers must transition to the Medical Device Single Audit Program (MDSAP) before January 1, 2019 in order to continue trading on the Canadian market.

Health Canada will end its Medical Devices Conformity Assessment System (CMDCAS) and only accept certificates issued under the MDSAP, an initiative whereby manufacturers are audited once for compliance with the standard and regulatory requirements of one or more of the following countries:  Australia, Brazil, Canada, Japan and the United States. Manufacturers that obtain MDSAP certificates will meet the quality management system requirements of the Medical Devices Regulations.

Licences already obtained using a CMDCAS certificate will be subject to suspension if they are not supported by a valid MDSAP certificate after the deadline. For manufacturers that only sell products in Canada, the regulatory requirements of the other MDSAP participating countries will not be audited.

Contact us today to discuss your quality management system requirements and to discover how regulatory intelligence and registration management system LICENSALE.COM® assists MedTech firms worldwide in gaining access to 100+ markets faster and more cost-effectively than ever before.

 

 

Back to Press Room

latest news
  • Feb 21 2018
    REGULATORY UPDATE - TECRES MEDICAL

    Saudi Arabia: Tecres Medical's Rally Bone Cements were approved for sale with LICENSALE.COM®. ...

    Read More
  • Feb 19 2018
    REGULATORY UPDATE - LUMINEX

    Brazil: Luminex's xTAG Cystic Fibrosis 71 Kit v2 was approved for sale with LICENSALE.COM®. ...

    Read More
  • Feb 1 2018
    REGULATORY UPDATE - LEXMARK

    UAE: Lexmark's Media Writer, PACS Scan and EHR Gateway were approved for sale with LICENSALE.COM®. ...

    Read More
  • Jan 30 2018
    REGULATORY UPDATE - SYNTHETIC MR

    USA: Synthetic MR's SyMRI Neuro was approved for sale with LICENSALE.COM®. ...

    Read More
  • Jan 9 2018
    REGULATORY UPDATE - NOVASIGHT

    EU: Novasight's Eyeswift was approved for sale with LICENSALE.COM®. ...

    Read More

VANCOUVER OFFICE

  • Phone +1 604.681.6888
  • Fax +1 604.681.6822
  • info@arazygroup.com
  •  
  • #350-1333 Johnston Street
  • Pier 32, Granville Island
  • Vancouver, British Columbia
  • Canada V6H 3R9

BACK TO TOP